New Line Therapy of Multiple Sclerosis

A tétel rövid nézete
dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem: Farmakológiai Intézethu_HU
dc.contributor.authorNasef, Azhar J.I.
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentDrimba, László
dc.contributor.opponentKovács, Péter
dc.contributor.opponentdeptKenézy Kórház, Aneszteziológiai tanszékhu_HU
dc.contributor.opponentdeptBelgyógyászati Intézet "A" részleghu_HU
dc.date.accessioned2014-07-29T13:22:36Z
dc.date.available2014-07-29T13:22:36Z
dc.date.created2013-06-24
dc.description.abstractThe thesis sheds light on the most frequent neuroinflammatory disease called Multiple Sclerosis. There's focus on the current and most reliable therapy of the disorder. The thesis also discusses the numerous trials and research of upcoming drugs that have become quite efficient as therapy. There are highlights on the antibody therapy of this immune disorder that have shown promising results for the patients. The therapy of accompanying symptoms have also been revised and discussed.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.coursespecOrvosbiológia-farmakológiahu_HU
dc.description.degreeBSc/BAhu_HU
dc.format.extent37hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/195472
dc.language.isoenhu_HU
dc.subjectmultiple sclerosishu_HU
dc.subjecttherapyhu_HU
dc.subject.dspaceoral drugshu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titleNew Line Therapy of Multiple Sclerosishu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)